Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H) (BIOMAX)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Sanidad de Castilla y Leon (SACYL)
University of Valladolid
Centro en Red de Medicina Regenerativa de Castilla y Leon
Citospin
Information provided by (Responsible Party):
Red de Terapia Celular
ClinicalTrials.gov Identifier:
NCT01389661
First received: July 5, 2011
Last updated: April 4, 2016
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)